The second round immunophenotyping test showed PCK, CD99, OCT3/4, CD117, S100, and HMB45 were all negative while only Syna was positive, which can rule out metastatic carcinoma, germ cell tumor, melanoma, and primitive neuroectodermal tumor. This evidence concerns the gene CD99 and metastatic carcinoma.